日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment

使用索尼德吉和维莫德吉治疗基底细胞癌患者的真实世界治疗模式:停药率和治疗期间的临床状况

Lebwohl, Mark G; Rigel, Darrell S; Eroglu, Zeynep; Barghout, Victoria E; Gupta, Deepshekhar; Zanardo, Enrico; Huynh, Lynn; Yenikomshian, Mihran A; Squittieri, Nicholas; Ferro, Thomas J; Patel, Kunal

Bezlotoxumab for prevention of Clostridioides difficile recurrence in patients with inflammatory bowel disease: a retrospective multicenter experience

贝洛妥珠单抗预防炎症性肠病患者艰难梭菌复发:一项回顾性多中心研究

Karime, Christian; Odah, Tarek; Hashash, Jana G; Pardi, Darrell S; Khanna, Sahil; Farraye, Francis A

Risk Factors, Clinical Features and Diagnostic Workup of Sclerosing Mesenteritis: a Single-Center Study of 219 Patients

硬化性肠系膜炎的危险因素、临床特征和诊断流程:一项纳入219例患者的单中心研究

Saha, Bibek; Rajagopal, Anjali; Tome, June; Pardi, Darrell S; Wang, Xiao Jing

Update on the Epidemiology and Management of Microscopic Colitis

显微镜下结肠炎的流行病学和治疗进展

Peery, Anne F; Khalili, Hamed; Münch, Andreas; Pardi, Darrell S

Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection

首次或多次复发性艰难梭菌感染患者胃肠道微生物组和胆汁酸谱的可比性

Bryant, Jessica A; Straub, Timothy J; Pardi, Darrell S; Litcofsky, Kevin D; Kelly, Colleen R; Chafee, Meghan E; Cohen, Stuart H; Khanna, Sahil; Berenson, Charles S; Wortman, Jennifer; Sims, Matthew; Ford, Christopher B; Lombardo, Mary-Jane; McGovern, Barbara H; von Moltke, Lisa; Kraft, Colleen S; Henn, Matthew R; Hasson, Brooke R

Real-world use of bezlotoxumab to prevent recurrent Clostridioides difficile infections: a single-center experience and meta-analysis

bezlotoxumab在预防复发性艰难梭菌感染中的真实世界应用:单中心经验和荟萃分析

Sehgal, Kanika; Berry, Parul; Tariq, Raseen; Pardi, Darrell S; Khanna, Sahil

Pearls From the Pros: Management of Refractory Microscopic Colitis

专家经验之谈:难治性显微镜下结肠炎的治疗

Tome, June; Pardi, Darrell S

The 4.2 ka event is not remarkable in the context of Holocene climate variability

4.2 ka 事件在全新世气候变率的背景下并不引人注目。

McKay, Nicholas P; Kaufman, Darrell S; Arcusa, Stéphanie H; Kolus, Hannah R; Edge, David C; Erb, Michael P; Hancock, Chris L; Routson, Cody C; Żarczyński, Maurycy; Marshall, Leah P; Roberts, Georgia K; Telles, Frank

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

更正:针对复发性艰难梭菌感染的微生物组疗法的3期临床试验的综合安全性和有效性分析

Kraft, Colleen S; Sims, Matthew; Silverman, Michael; Louie, Thomas J; Feuerstadt, Paul; Huang, Edward S; Khanna, Sahil; Berenson, Charles S; Wang, Elaine E L; Cohen, Stuart H; Korman, Louis; Lee, Christine; Kelly, Colleen R; Odio, Alberto; Cook, Paul P; Lashner, Bret; Ramesh, Mayur; Kumar, Princy; De, Ananya; Memisoglu, Asli; Lombardi, David A; Hasson, Brooke R; McGovern, Barbara H; von Moltke, Lisa; Pardi, Darrell S

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

针对复发性艰难梭菌感染的微生物组疗法的3期临床试验的综合安全性和有效性分析

Kraft, Colleen S; Sims, Matthew; Silverman, Michael; Louie, Thomas J; Feuerstadt, Paul; Huang, Edward S; Khanna, Sahil; Berenson, Charles S; Wang, Elaine E L; Cohen, Stuart H; Korman, Louis; Lee, Christine; Kelly, Colleen R; Odio, Alberto; Cook, Paul P; Lashner, Bret; Ramesh, Mayur; Kumar, Princy; De, Ananya; Memisoglu, Asli; Lombardi, David A; Hasson, Brooke R; McGovern, Barbara H; von Moltke, Lisa; Pardi, Darrell S